Zobrazeno 1 - 10
of 42
pro vyhledávání: '"risk of cardiovascular complications"'
Autor:
S. N. Tolpygina, S. Yu. Martsevich
Publikováno v:
Klinicist, Vol 14, Iss 1-2, Pp 24-33 (2020)
Despite a gradually decreased mortality from cardiovascular diseases, including coronary artery disease (CAD), they remain the main cause of death in the world. In the coming decades, an increased prevalence of CAD is expected. While methods that are
Externí odkaz:
https://doaj.org/article/c2461e73b66541f8a8aeda178b5e6777
Publikováno v:
Терапевтический архив, Vol 91, Iss 9, Pp 38-46 (2019)
Aim. To evaluate efficacy and safety of reduced dose of direct oral anticoagulants (DOACs) as part of triple antithrombotic therapy in AF patients, undergoing elective percutaneous coronary intervention (PCI), and to identify factors, associated with
Externí odkaz:
https://doaj.org/article/d6b647db4f9242c0a3f07da871f62096
Autor:
G. P. Arutyunov, S. A. Boytsov, M. I. Voevoda, O. M. Drapkina, V. V. Kukharchuk, A. I. Martynov, M. V. Shestakova, V. S. Gurevich, I. V. Sergienko, A. S. Alieva, N. M. Akhmedzhanov, M. G. Bubnova, A. S. Galyavich, I. G. Gordeev, M. V. Yezhov, Yu. A. Karpov, V. O. Konstantinov, S. V. Nedogoda, E. M. Nifontov, Y. A. Orlova, A. V. Panov, S. A. Saiganov, V. V. Skibitsky, E. I. Tarlovskaya, S. A. Urazgildeeva, Yu. Sh. Khalimov
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 9, Pp 44-51 (2019)
In opinion the Expert council provides management tactics for patients with hypertriglyceridemia (HTG). It is demonstrated that HTG is a common condition in overweight patients and is an important component of residual risk. HTG creates additional co
Externí odkaz:
https://doaj.org/article/1eaf4fd217b84091ba3e9c5568297eeb
Autor:
G. P. Arutyunov, S. A. Boytsov, M. I. Voyevoda, V. S. Gurevich, O. M. Drapkina, V. V. Kukharchuk, A. I. Martynov, I. V. Sergiyenko, M. V. Shestakova, A. S. Aliyeva, N. M. Akhmedzhanov, M. G. Bubnova, А. S. Galyavich, I. G. Gordeyev, M. V. Ezhov, Yu. A. Karpov, V. O. Konstantinov, S. V. Nedogoda, E. M. Nifontov, Ya. A. Orlova, A. V. Panov, S. A. Sayganov, V. V. Skibitskiy, E. I. Tarlovskaya, S. A. Urazgildeyeva, Yu. Sh. Khalimov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 15, Iss 2, Pp 282-288 (2019)
Tactics for the management of patients with hypertriglyceridemia (HTG) is provided in the conclusion of the Advisory Board. It is demonstrated that HTG is quite prevalent in patients with excessive body weight and is an important component of residua
Externí odkaz:
https://doaj.org/article/59663c0f481145f497a617261716fda8
Autor:
S. Yu. Martsevich, Yu. V. Lukina, N. P. Kutishenko, N. A. Dmitrieva, S. V. Blagodatskikh, O. V. Lerman, T. A. Gomova, S. I. Drozdetsky, V. V. Skibitskiy, E. A. Kudryashov, N. F. Puchinyan
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 14, Iss 6, Pp 891-900 (2019)
Aim. To study adherence to treatment with generic statins prescribed to patients with high and very high cardiovascular risk in routine clinical practice, as well as the possible impact of educational training of doctors on compliance with clinical g
Externí odkaz:
https://doaj.org/article/cb7e5e7b45e74753a38c2cffce01bd0a
Publikováno v:
Терапевтический архив, Vol 90, Iss 9, Pp 92-100 (2018)
The urgency of the study is determined by the lack of data necessary in order to assess the safety of prolonged use of proton pump inhibitors (PPI) in patients with IHD combined with anti-aggregant therapy. The aim of the study was to study the relat
Externí odkaz:
https://doaj.org/article/4085fca02c9144c58f56d7f8119e6267
Autor:
Z N Blankova, N S Aslanyan
Publikováno v:
Системные гипертензии, Vol 14, Iss 2, Pp 51-55 (2017)
Introduction. The evaluation of therapy effectiveness in patients at high risk of cardiovascular complications includes the evaluation of target organs condition. A complex approach means follow-up control of laboratory and instrumental data. Materia
Externí odkaz:
https://doaj.org/article/d3f592444bac4622979cc44ed2b9a122
Autor:
Blankova Z.N., Aslanyan N.S.
Publikováno v:
Системные гипертензии, Vol 14, Iss 2, Pp 51-55 (2017)
Introduction. The evaluation of therapy effectiveness in patients at high risk of cardiovascular complications includes the evaluation of target organs condition. A complex approach means follow-up control of laboratory and instrumental data. Materia
Externí odkaz:
https://doaj.org/article/61cac1d1c11a449da6994fb847949e36
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 8, Iss 2, Pp 205-210 (2015)
Acetylsalicylic acid (ASA) use in the primary and secondary prevention of cardiovascular diseases is focused. Mode of ASA disaggregation action is discussed. Data of randomized controlled trials on ASA efficacy and safety in primary and secondary pre
Externí odkaz:
https://doaj.org/article/e4378d8e7c2e49c2b248a1b9b4a60281